US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 0.759
  • +0.007+0.89%
Close May 1 16:00 ET
  • 0.770
  • +0.011+1.50%
Post 19:33 ET
41.47MMarket Cap-346P/E (TTM)

Cara Therapeutics Key Stats

Cara Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 4, 2024

Revenue(YoY)

3.00M

-7.88%
EPS(YoY)

-0.60

-7.14%

Strong Buy

Apr 30, 2024

Cara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.443M--
--2024/Q1-- / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--
Aug 7, 20232023/Q26.933M / 6.695M--
May 15, 20232023/Q16.165M / 4.982M--
Mar 6, 20232022/Q43.261M / 14.502M--
Nov 7, 20222022/Q310.813M / 8.855M--
Aug 8, 20222022/Q223.003M / 21.035M--
May 9, 20222022/Q14.790M / 2.260M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.443M--
--2024/Q1-- / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--
Aug 7, 20232023/Q26.933M / 6.695M--
May 15, 20232023/Q16.165M / 4.982M--
Mar 6, 20232022/Q43.261M / 14.502M--
Nov 7, 20222022/Q310.813M / 8.855M--
Aug 8, 20222022/Q223.003M / 21.035M--
May 9, 20222022/Q14.790M / 2.260M--

Unlock Free Earnings Estimates

Cara Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg